Recommendations for the Management of Uveitis Associated With Juvenile Idiopathic Arthritis: The Czech and Slovak adaptation of SHARE Initiative.

Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in children and uveitis is its most important extra-articular manifestation. Evidence-based recommendations are available only to a limited extent and therefore JIA associated uveitis management is mostly based on physicians experience. Consequently, treatment practices differ widely, both nationally and internationally. Therefore, an effort to optimize and publish recommendations for the care of children and young adults with rheumatic diseases was launched in 2012 as part of the international project SHARE (Single Hub and Access Point for Pediatric Rheumatology in Europe) to facilitate clinical practice for paediatricians and (paediatric) rheumatologists. The aim of this work was to translate published international SHARE recommendations for the diagnosis and treatment of JIA associated uveitis and to adapt them for use in the Czech and Slovak Republics. International recommendations were developed according to the standard methodology of the European League against Rheumatism (EULAR) by a group of nine experienced paediatric rheumatologists and three experts in ophthalmology. It was based on a systematic literature review and evaluated in the form of an online survey and subsequently discussed using a nominal group technique. Recommendations were accepted if > 80% agreement was reached (including all three ophthalmologists). A total of 22 SHARE recommendations were accepted: 3 on diagnosis, 5 on disease activity assessment, 12 on treatment and 2 on future recommendations. Translation of the original text was updated and modified with data specific to the czech and slovak health care systems and supplemented with a proposal for a protocol of ophthalmological dispensarization of paediatric JIA patients and a treatment algorithm for JIA associated uveitis. Conclusion: The aim of the SHARE initiative is to improve and standardize care for paediatric patients with rheumatic diseases across Europe. Therefore, recommendations for the diagnosis and treatment of JIA-associated uveitis have been formulated based on the evidence and agreement of leading European experts in this field.

[Kawasaki disease and its ocular manifestations]. / Kawasakiho choroba a její ocní príznaky.

The article describes one of the occurring types of vasculitis in children. Discussing the essential manifestations of the disease it focuses on ocular symptoms as one of the major criteria. The diagnosis is often done on the basis of a clinical description further specified by laboratory and instrument techniques. Awareness of the symptoms typical of the disease, frequently identifiable even macroscopically, facilitates the early diagnosis. A differential diagnosis of febrile responses may include a wide range of possibilities considered including faulty conclusions consequently causing a delay in therapy, which may be fatal. With the Kawasaki disease a bilateral injection of bulbar conjunctiva is the first signal of objectification followed by frequent acute bilateral iridocyclitis with delayed development and prolonged duration. Thus the problem of a red eye and febrile responses may suggest the above-mentioned serious diagnosis, which is at present, however, well-curable and recognisable with stress put on the time factor.